Counterpoint. Cancer vaccines: Single-epitope anti-idiotype vaccine versus multiple-epitope antigen vaccine

Cancer Immunology Immunotherapy

Volumn 49, Issue 3, 2000, Pages 133-141

  Bhattachary Chatterjee, Malaya ^a   Nath Baral, Rathindra ^a   Chatterjee, Sunil K ^a   Das, Ruma ^a   Zeytin, Hasan ^a   Chakraborty, Mala ^a   Foon, Kenneth A ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

Anti idiotype antibodies; Immune response; Vaccine

Indexed keywords

CANCER ANTIBODY; CANCER VACCINE; IDIOTYPIC ANTIBODY; TUMOR ANTIGEN;

ARTICLE; CANCER IMMUNOTHERAPY; CLINICAL TRIAL; DIAGNOSTIC APPROACH ROUTE; DRUG EFFICACY; DRUG FORMULATION; DRUG SPECIFICITY; ERYTHEMA; HUMAN; HUMAN CELL; HUMAN TISSUE; INJECTION PAIN; PRIORITY JOURNAL; VACCINATION;

ADJUVANTS, IMMUNOLOGIC; ALUM COMPOUNDS; ANIMALS; ANTIBODIES, ANTI-IDIOTYPIC; ANTIBODIES, MONOCLONAL; ANTIBODIES, NEOPLASM; ANTIGENS, NEOPLASM; BREAST NEOPLASMS; CANCER VACCINES; CARCINOEMBRYONIC ANTIGEN; CLINICAL TRIALS; COLORECTAL NEOPLASMS; EPITOPES; EVALUATION STUDIES; GANGLIOSIDES; GLYCOLIPIDS; GLYCOPROTEINS; HUMANS; IMMUNIZATION; LEUKEMIA, T-CELL, ACUTE; MELANOMA; MICE; MICE, INBRED C57BL; MODELS, IMMUNOLOGICAL; MOLECULAR MIMICRY; NEOPLASMS; NEOPLASMS, EXPERIMENTAL; TREATMENT OUTCOME;

EID: 0033936179     PISSN: 03407004     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002620050612     Document Type: Article

References (50)

1. Adluri S, Gilewski T, Zhang S, Ramnath V, Ragupathi G, Livingston PO (1999) Specificity analysis of sera from breast cancer patients vaccinated with Muc1-KLH plus QS-21. Br J Cancer 79: 1806-1812
2. Bhattacharya-Chatterjee M, Kohler H (1990) Anti-idiotype tumor vaccines. Adv Exp Med Biol 251: 113-128
3. Bhattacharya-Chatterjee M, Pride MW, Seon BK, Köhler H (1987) Idiotype vaccines against human T-cell acute lymphoblastic leukemia (T-ALL). I. Generation and characterization of biologically active monoclonal anti-idiotopes. J Immunol 139: 1354-1360
4. Bhattacharya-Chatterjee M, Chatterjee SK, Vasile S, Seon BK, Köhler H (1988) Idiotype vaccines against human T-cell leukemia. II. Generation and characterization of a monoclonal idiotype cascade (Abl, Ab2 and Ab3). J Immunol 141: 1398-1403
5. Bhattacharya-Chatterjee M, Mukerjee S, Biddle W, Foon KA, Köhler H (1990) Murine monoclonal anti-idiotype antibody as a potential network antigen for human carcinoembryonic antigen. J Immunol 145: 2758-2765
6. Bhattacharya-Chatterjee M, Mrozek E, Mukerjee S, Ceriani RL, Köhler H, Foon KA (1994) Anti-idiotype antibodies as potential therapeutic agents for human breast cancer. In: Ceriani RL (ed) Proceedings of the 5th International Workshop on Breast Cancer Therapy and Immunology. Plenum New York, pp 387-401
7. Campbell MJ, Esserman L, Levy R (1988) Immunotherapy of established murine B-cell lymphoma. Combination of idiotype and cyclophosphamide. J Immunol 141: 3227-3233
8. Chakraborty M, Foon KA, Köhler H, Bhattacharya-Chatterjee M (1995) Preclinical evaluation in non-human primates of an anti-idiotypic antibody that mimics the carcinoembryonic antigen. J Immunother 18: 95-103
9. Chakraborty M, Mukherjee S, Foon KA, Ceriani R, Köhler H, Bhattacharya-Chatterjee M (1995) Induction of human breast cancer-specific antibody response in cynomolgus monkeys by a murine monoclonal anti-idiotype antibody. Cancer Res 55: 1525-1530
10. Chatterjee SK, Tripathi PK, Chakraborty M, Yannelli J, Wang H, Foon KA, Maier CC, Blalook JE, Bhattacharya-Chatterjee M (1998) Molecular mimicry of carcinoembryonic antigen by peptides derived from the structure of an anti-idiotype antibody. Cancer Res 58: 1217-1224
11. Chen JJ, Saeki Y, Shi L, Köhler H (1989). Syngernistic antitumor effects with combined "internal image" anti-idiotypes and chemotherapy. J Immunol 143: 1053-1057
12. Conry RM, LoBuglio AF, Loechel F, Moore SE, Sumerel LA, Barlow DL, Pike J, Curiel DT (1995) A carcinoembryonic antigen polynucleotide vaccine for human clinical use. Cancer Gene Ther 2: 33-38
13. Durant LG, Doran M, Austin EB, Robins RA (1995) Induction of cellular immune responses by a murine monoclonal anti-idiotypic antibody recognizing the 791Tgp72 antigen expressed on colorectal, gastric and ovarian tumors. Int J Cancer 61: 62-66
14. Foon KA, Oseroff AR, Vaickus L, Greenberg S, Russel D, Bernstein Z, Pincus S, Köhler H, Seon BK, Tahaoglu E, Beers T, Chakraborty M, Bhattacharya-Chatterjee M (1995) Immune responses in patients with T-cell lymphoma treated with an anti-idiotype antibody mimicking a highly restricted T-cell antigen. Clin Cancer Res 1: 1285-1294
15. Foon KA, Chakraborty M, John WJ, Sherratt A, Köhler H, Bhattacharya-Chatterjee M (1995) Immune response to the carcinoembryonic antigen in patients treated with anti-idiotype vaccine. J Clin Invest 96: 334-342
16. Foon KA, John WJ, Chakraborty M, Sherratt A, Garrison J, Flett M, Bhattacharya-Chatterjee M (1997) Clinical and immune responses in advanced colorectal cancer patients treated with anti-idiotype monoclonal antibody vaccine that mimics the carcinoembryonic antigen. Clin Cancer Res 3: 1267-1276
17. Foon KA, Sen G, Hutchins L, Kashala OL, Baral R, Banerjee M, Chakraborty M, Garrison J, Reisfeld RA, Bhattacharya-Chatterjee M (1998) Antibody responses in melanoma patients immunized with an anti-idiotype antibody mimicking disialoganglioside GD2. Clin Cancer Res 4: 1117-1124
18. Foon KA, John WJ, Chakraborty M, Das R, Teitelbaum A, Garrison J, Kashala O, Chatterjee SK, Bhattacharya-Chatterjee M (1999) Clinical and immune responses in resected colon cancer patients treated with anti-idiotype monoclonal antibody vaccine that mimics the carcinoembryonic antigen. J Clin Oncol 17: 2889-2895
19. Foon KA, Lutzky J, Baral RN, Yannelli JR, Hutchins L, Tietelbaum A, Kashala OL, Das R, Garrison J, Reisfeld RA, Bhattacharya-Chatterjee M (2000) Clinical and immune responses in advanced melanoma patients immunized with an anti-idiotype antibody mimicking disialoganglioside GD2. J Clin Oncol 18: 376-384
20. Handgretinger R, Baader P, Dopfer R, Klingebiel T, Reuland P, Treuner J, Reisfeld RA, Niethammer D (1992) A phase I study of neuroblastoma with the anti-ganglioside GD2 antibody 14G2a. Cancer Immunol Immunother 35: 199-204
21. Herlyn D, Wettendorf M, Schmoll E, Hopoulos D, Schedel I, Dreikhausen U, Raab R, Ross AH, Jaksche H, Scriba M, Koprowski H (1987) Anti-Id immunization of cancer patients: modulation of immune response. Proc Natl Acad Sci USA 84: 8055-8059
22. Jerne NK (1974) Towards a network theory of the immune system. Ann Immunol Paris 125C: 373-389
23. Kaminski MS, Kitamura K, Maloney DG, Levy R (1987) Idiotype vaccination against murine B-cell lymphoma Inhibition of tumor immunity by free idiotype protein. J Immunol 138: 1289-1296
24. Kennedy RC, Dreesman GR, Butel JS, Lanford RE (1985) Suppression of in vivo tumor formation induced by simian virus 40-transformed cells in mice receiving anti-idiotypic antibodies. J Exp Med 161: 1432-1439
25. Koprowski H, Herlyn D, Lubeck M, DeFreitas E, Sears HF (1984) Human anti-idiotypc antibodies in cancer patients: Is the modulation of the immune response beneficial for the patient? Proc Natl Acad Sci USA 81: 216-219
26. Lindenmann J (1973) Speculations on idiotypes of homobodies. Ann Immunol Paris 124: 171-184
27. Livingston PO (1995) Approaches to augmenting the immunogenicity of melanoma gangliosides: From whole melanoma cells to ganglioside - KLH conjugate vaccines. Immunol Rev 145: 147-166
28. Livingston PO, Adluri S, Helling F, Yao T-J, Kensil CR, Newman MJ, Marciani D (1994) Phase I trial of immunological adjuvant QS-21 with a GM2 ganglioside - KLH conjugate vaccine in patients with malignant melanoma. Vaccine 12: 1275-1280
29. Maruyama H, Benden A, Zaloudik J, Koido T, Li W, Taupin J-L, Acres B, Soumasundaram R, Prewett M, Herlyn D (1996) Monoclonal anti-idiotypic antibody functionally mimics the human gastrointestinal carcinoma epitope GA733. Int J Cancer 65: 547
30. Mittelman A, Chen ZJ, Yank H, et al (1992) Active specific immunothreapy in patients with melanoma. J Clin Invest 86: 2136-2144
31. Mittelman A, Chen ZJ, Yank H, et al (1992) Human high molecular weight melanoma-associated antigen (HMW-MAA) mimicry by mouse anti-idiotypic monoclonal antibody MK2-23: induction of humoral anti-HMW-MAA immunity and prolongation of survival in patients with stage IV melanoma. Proc Natl Acad Sci USA 89: 466-470
32. Munn RK, Hutchins L, Garrison J, Sen G, Chakraborty M, Baral R, Romond E, Bhattacharya-Chatterjee M, Foon KA (1998) Immune responses in patients with breast cancer treated with an anti-idiotypic antibody that mimics the human milk fat globule (HMFG) antigen. Proc Am Soc Clin Oncol 17: 428
33. Nelson KA, George E, Swenson C, Forstrom JW, Hellstrom KE (1987) Immunotherapy of murine sarcomas with auto-anti-idiotypic monoclonal antibodies which bind to tumor-specific T cells. J Immunol 139: 2110-2117
34. Pervin S, Chakraborty M, Bhattacharya-Chatterjee M, Zeytin H, Foon KA, Chatterjee SK (1997) Induction of anti-tumor immunity by an anti-idiotype antibody mimicking carcinoembyronic antigen. Cancer Res 57: 728-734
35. Raychaudhuri S, Saeki Y, Chen JJ, Köhler H (1978) Tumor-specific idiotype vaccine IV Analysis of the idiotypic network in tumor immunity. J Immunol 139: 3902-3910
36. Raychaudhuri S, Saeki Y, Fuji H, Köhler H (1986) Tumor-specific idiotype vaccines I Generation and characterization of internal image tumor antigen. J Immunol 137: 1743-1749
37. Raychaudhuri S, Saeki Y, Chen JJ, Iribe H, Fuji H, Köhler H (1987) Tumor-specific idiotype vaccines II Analysis of the tumor-related network response induced by the tumor and by internal image antigens (Ab2β). J Immunol 139: 271-278
38. Raychaudhuri S, Saeki Y, Chen JJ, Iribe H, Fuji H, Köhler H (1987) Tumor specific idiotype vaccines III Induction of T helper cells by anti-idiotype and tumor cells. J Immunol 139: 2096-2102
39. Reithmüller G, Holz E, Schlimok G, Schmiegel W, Raab R, Hoffken K, Gruber R, Funke I, Pichlmaier H, Hirche H, Bugrisch P, Witte J, Pichlmayer R (1998) Monoclonal antibody therapy for resected Dukes' C colorectal cancer: seven year outcome of a multi-center randomized trial. J Clin Oncol 16: 1788
40. Robins RA, Dentol GWL, Hardcastle JD, Austin EB, Baldwin RW, Durrant LG (1991) Anti-tumor immune response and interleukin 2 production induced in colorectal cancer patients by immunization with human monoclonal anti-idiotypic antibody. Cancer Res 51: 5425-5429
41. Ruiz PJ (1998) Immunity to mutant p53 and tumor rejection induced by idiotpic immunization. Nature Med 4: 710-712
42. Samanci A, Yi Q, Fagerberg J, Strigard K, Smith G, Ruden U, Wahren B, Mellstedt H (1998) Pharmacological administration of granulocyte/macrophage-colony-stimulating factor is of significant importance for the induction of a strong humoral and cellular response in patients immunized with recombinant carcinoembryonic antigen. Cancer Immunol Immunother 47: 131-142
43. Sen G, Chakraborty M, Foon KA, Reisfeld RA, Bhattacharya-Chatterjee M (1997) Preclinical evaluation in nonhuman primates of murine monoclonal anti-idiotype antibody that mimics the disialoganglioside GD2. Clin Cancer Res 3: 1969-1976
44. Sen G, Chakraborty M, Foon KA, Reisfeld RA, Bhattacharya-Chatterjee M (1998) Induction of IgG antibodies by an anti-idiotype antibody mimicking disialoganglioside GD2. J Immunother 21: 76-83
45. Somasundaram R, Zaloudik J, Jacob L, Benden A, Sperlagh M, Hart E, Marks G, Kane M, Mastrangelo M, Herlyn D (1995) Induction of an antigen-specific T and B cell immunity in colon carcinoma patients by anti-idiotypic antibody. J Immunol 155: 3253-3261
46. Stevenson FK, Gordon J (1983) Immunization of idiotypic immunoglobulin protects against development of B lymphocytic leukemia, but emerging tumor cells can evade antibody attack by modulation. J Immunol 13: 970
47. Sugai S, Palmer DW, Talal N, Witz IP (1974) Protective and cellular immune responses to idiotypic determinants on cells from a spontaneous lymphoma of NZB-NZW F1 mice. J Exp Med 140: 1547-1558
48. Terry WD, Rosenberg SA (eds) (1982) Immunotherapy of human cancer. Elsevier/North-Holland Biomedical, Amsterdam
49. Tsang KY, Zaremba S, Nieroda CA, Zhu MZ, Hamilton JM, Schlom J (1995) Generation of human cytotoxic T cells specific for human carcinoembryonic antigen epitopes from patients immunized with recombinant vaccinia - CEA vaccine. J Natl Cancer Inst 87: 982-990
50. Weigle WO (1961) The immune response of rabbits tolerant to bovine serum albumin to the injection of other heterologous serum albumins. J Exp Med 114: 111-125